test

Harold Schaaff

@Soleus Capital Management, L.p.

Latest period2024 - Q3ReportedManaged Assets$1.291BTotal holdings87
Assets growth rate13.9%Assets growth rate (2-Q avg)-0.97%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Soleus Capital Management, L.p.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 87 positions.

Assets under management

The assets under management (AUM) of Soleus Capital Management, L.p. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.291B in assets, with a quarterly growth rate of 13.9% and a 2-quarter average growth rate of -0.97%. The portfolio is managed by Harold Schaaff, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
TGTXTg Therapeutics Inc
Recent Activity
Decreased -30.47%
4.6%
$59.283M
2.535M shares@ $23.4 avg price
AXGNAxogen Inc
Recent Activity
Decreased -9.07%
3.27%
$42.143M
3.006M shares@ $14.03 avg price
UTHRUnited Therapeutics Corp Del
Recent Activity
Decreased -27.98%
2.83%
$36.514M
101,894 shares@ $358.36 avg price
RVMDRevolution Medicines Inc
Recent Activity
Decreased -17.7%
2.48%
$31.953M
704,584 shares@ $45.35 avg price
SRDXSurmodics Inc
Recent Activity
Decreased -18.42%
1.92%
$24.73M
637,698 shares@ $38.78 avg price
NRIXNurix Therapeutics Inc
Recent Activity
Decreased -48.15%
1.86%
$23.949M
1.066M shares@ $22.48 avg price
CSTLCastle Biosciences Inc
Recent Activity
Decreased -22.4%
1.47%
$18.89M
662,332 shares@ $28.53 avg price
BGNEBeigene Ltd
Recent Activity
Decreased -39.9%
1.44%
$18.578M
82,750 shares@ $224.52 avg price
EOLSEvolus Inc
Recent Activity
Decreased -9.92%
1.31%
$16.81M
1.038M shares@ $16.2 avg price
ALNYAlnylam Pharmaceuticals Inc
Recent Activity
Decreased -17.15%
1.27%
$16.337M
59,400 shares@ $275.03 avg price